HC Wainwright & Co. Reiterates Buy on Pacira BioSciences, Maintains $38 Price Target
HC Wainwright & Co. analyst Douglas Tsao reiterates Pacira BioSciences (NASDAQ: PCRX ) with a Buy and maintains $38 price target.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.